Sign in
Taking people in United StatesPhase 1

PT150 Drug for Use in Alcohol Use Disorder

Key facts

Who runs it
Pop Test Oncology LLC
Where
Lexington, United StatesSee the site
Trial code
Status
Recruiting
Phase
Phase 1
People taking part
34 people, planned
Started
1 Feb 2025
Expected to end
31 Jul 2028
Type of study
Interventional, 2 groups
Treatments tested
  • alcohol
  • Stress-Induction
  • PT150
Record updated
16 September 2026

Who can take part

Age
21 years to 55 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • Meet diagnostic criteria for AUD (moderate or severe) per the Diagnostic and Statistical Manual of Mental Disorders - 5th edition (DSM-5)
  • Not seeking treatment at the time of the study
  • English-speaking
  • Between the ages of 21 and 55 years (individuals under 21 are excluded based on the recommendations of NIAAA that alcohol should not be administered to individuals under the legal drinking age)
  • Abstinent from alcohol no more than 3 days per week on average
  • Physically and psychiatrically healthy other than the diagnoses for AUD or tobacco use disorder
  • ECG, read by cardiologist, within normal limits
  • Body mass index of 19 - 35
  • Using an effective form of birth control (e.g., birth control pills, surgical sterilization, condoms, IUD, cervical cap with a spermicide or abstinence) if female
  • Able to abstain from ALC for 12 hours prior to sessions
  • No contraindications to ALC or PT150

Who cannot take part

  • Participants scoring >6 on the Clinical Institute Withdrawal Assessment for Alcohol Revised (CIWA-Ar); the CIWA-Ar will be administered prior to each experimental session participants who score >6 will be excluded further participation
  • Meet diagnostic criteria for SUDs, save nicotine, other than AUD that in the opinion of a study physician would require medical intervention (e.g., opioid use disorder) or compromise the well-being of the participant
  • Have a history of serious physical disease or current physical disease (e.g., impaired cardiovascular functioning, histories of seizure, head trauma or CNS tumors)
  • Have a current or past history of psychiatric disorder that would interfere with participation (e.g., psychotic [schizophrenia, schizoaffective]), bipolar, major depressive disorder)
  • Have abnormal blood chemistry, complete blood count or urinalysis values deemed clinically significant
  • Have had suicidal ideations in the past 90 days
  • Pregnant or nursing
  • Are unwilling/unable to comply with study procedures

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 21 and 55 years old?

This trial is currently available in United States.

  • University of KentuckyLexington, United StatesContact: Kelsey PadgettTaking people

About the trial

What the trial wants to find out

The goal of this study is to learn if PT150 can reduce the behavioral and physical effects of stress, alcohol, and alcohol use in people with alcohol use disorder.

The 2 groups in the trial

  • PT150 with alcohol consumption then stressTreatment being tested

    Following at least five days of maintenance on a randomized dose of PT150, participants will complete an experimental alcohol administration session. No less than 24 hours later, participants will then complete an experimental stress induction session.

    Treatment: alcohol, Stress-Induction, and PT150

  • PT150 with stress then alcohol consumptionTreatment being tested

    Following at least five days of maintenance on a randomized dose of PT150, participants will complete an experimental session involving stress induction. No less than 24 hours later, participants will then complete an experimental alcohol administration session.

    Treatment: alcohol, Stress-Induction, and PT150

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Selective Glucocorticoid Receptor Antagonism in Alcohol Use Disorder: A Human Laboratory Study
Criteria questions
Built from NCT06712602, who can take part
Record updated
16 September 2026